Bitte geben Sie Ihren Suchbegriff ein

Willkommen
Angiologie Beschreibung
Erkrankungen der Venen
Erkrankungen der Arterien
Diagnostik und klinische
Untersuchung
Therapie und Behandlung
Zusatzmassnahmen
Arterielle Veschlußkrankheit
bei Diabetes mellitus
Ordination: Innere Medizin -
Angiologie / Gonzagagasse
Evangelisches Krankenhaus -
Klinik fuer Innere Medizin -
Angiologie und Kardiologie
Prim. Dr. Thomas Maca
Publikationen 1
Publikationen 2
Patienteninformation
 
ORIGINALARBEITEN (Erstautorschaft) - Publikationsliste mit Impactfaktoren
T. Maca, W. Mlekusch, L. Doweik, A. C. Budinsky, M. Bischof, E. Minar, M. Schillinger.
INFLUENCE AND INTERACTION OF DIABETES AND LIPOPROTEIN (a) SERUM LEVELS ON MORTALITY
OF PATIENTS WITH PERIPHERAL ARTERY DISEASE European Journal of Clinical Investigation.
2007, 37(3):180-6. IF 2.847
T.H. Maca, Schillinger M, Hamwi A, Mlekusch W, Sabeti S, Wagner O, Minar E.
INSULIN, C-PEPTIDE, AND RESTENOSIS AFTER FEMORAL ARTERY BALLOON ANGIOPLASTY
IN TYPE II DIABETIC AND NONDIABETIC PATIENTS.Journal of Vascular Interventional
Radiology. 2008, 16(1):31-5. IF 1.68
T.H. Maca, R.Ahmadi, K.Derfler, H. Ehringer, M.E. Gschwandtner, W.H. Hörl, R.Katzenschlager,
E.Müller-Knespel, R. Koppensteiner, E. Minar, B. Schneider, A.Stümpflen, A. Ugurluoglu, E.Minar.
INFLUENCE OF LIPOPROTEIN(a) ON RESTENOSIS AFTER FEMOROPOPLITEAL PERCUTANEOUS
TRANSLUMINAL ANGIOPLASTY IN TYPE II DIABETIC PATIENTS. CORRELATION TO RESTENOSIS
DESPITE LOWER LP(a) IN NIDDM. Diabetic Medicine 2002, 19 (4): 300-6. 2.73
Maca Th, Ahmadi R, Derfler K, Hörl WH, Koppensteiner R, Minar E, Schneider B, Stümpflen A,
Ehringer H.ELEVATED LIPOPROTEIN(a) INCREASES THE INCIDENCE OF RESTENOSIS AFTER
FEMOROPOPLITEAL PTA. RATIONALE FOR THE HIGHER RISK OF RECURRENCES IN FEMALES?
Atherosclerosis 1996; 127 (1): 27-34. 2.919

T.Maca, P.Fasching, M.Rohac, M.Stur, B.Schneider und W.Waldhäusl.
SEKUNDÄRPRÄVENTION DER DIABETISCHEN RETINOPATHIE BEI DIABETES MELLITUS TYP I:
ABHÄNGIGKEIT VOM RETINOPATHIESTATUS VOR DER INTERVENTION.
Deutsche Medizinische Wochenschrift 1996; 121: 257-262. 0.681
auch japanisch erschienen:
T.Maca, P.Fasching, M.Rohac, M.Stur, B.Schneider und W.Waldhäusl.SECONDARY PREVENTION
OF DIABETIC RETINOPATHY IN TYPE I (IDDM) DIABETES MELLITUS: DEPENDENCE ON
RETINOPATHY STATUS BEFORE INTERVENTION.D.M.W. Japan Ltd. 1996; 18 (3): 323-328. (0.681)
ORIGINALARBEITEN (Coautorschaft)
Giurgea AG, Margeta C, Maca T, Rezaie-Majd A, Bucek RA, Manavi M, Afarideh R, Minar E,
Baghestanian M.SIMVASTATIN REDUCES SERUM LEVEL OF VASCULAR ENDOTHELIAL GROWTH
FACTOR IN HYPERCHOLESTEROLEMIC PATIENTS. 1.99
Luksch A, Rainer G, Koyuncu D, Ehrlich P, Maca T, Gschwandtner ME, Vass C, Schmetterer L.
EFFECT OF NIMODIPINE ON OCULAR BLOOD FLOW AND COLOUR CONTRAST SENSITIVITY IN
PATIENTS WITH NORMAL TENSION GLAUCOMA.Br J Ophthalmol. 2008 Jan;89(1):21-5. 1.76
Al-Awami M, Schillinger M, Maca T, Pollanz S, Minar E.
LOW LEVEL LASER THERAPY FOR TREATMENT OF PRIMARY AND SECONDARY RAYNAUD'S
PHENOMENON.Vasa. 2004 Feb;33(1):25-9. 0.82
Doweik L, Maca T, Schillinger M, Budinsky A, Sabeti S, Minar E.FIBRINOGEN PREDICTS MORTALITY
IN HIGH RISK PATIENTS WITH PERIPHERAL ARTERY DISEASE.
Eur J Vasc Endovasc Surg. 2003 Oct;26(4):381-6. 1.68
Schwarz C, Mitterbauer C, Boczula M, Maca T, Funovics M, Heinze G, Lorenz M, Kovarik J,
Oberbauer R.FLOW MONITORING: PERFORMANCE CHARACTERISTICS OF ULTRASOUND
DILUTION VERSUS COLOR DOPPLER ULTRASOUND COMPARED WITH FISTULOGRAPHY.
Am J Kidney Dis. 2003 Sep;42(3):539-45. 3.61
Rezaie-Majd A, Prager GW, Bucek RA, Schernthaner GH, Maca T, Kress HG, Valent P,
Binder BR, Minar E and Baghestanian M. SIMVASTATIN REDUCES THE EXPRESSION
OF ADHESION MOLECULES IN CIRCULATING MONOCYTES FROM HYPERCHOLESTEROLEMIC
PATIENTS.Arterioscl Thromb Vasc Biol 2003 Mar;23(3):397-403. 5.11
Ziegler S, Maca T, Alt E, Speiser W, Schneider B, Minar E.MONITORING OF ANTIPLATELET
THERAPY WITH PFA-100®IN PERIPHERAL ANGIOPLASTY PATIENTS.
Platelets 2002 Dec;13(8):493-7. 0.78
Schillinger M, Mlekusch W, Haumer M, Sabeti S, Maca T, Minar E.
RELATION OF SMALL ARTERY COMPLIANCE AND LIPOPROTEIN (a) IN PATIENTS WITH
ATHEROSCLEROSIS.Am J Hypertens. 2002 Nov;15(11):980-5. 2.75
Mlekusch W., Schillinger M., Sabeti S., Haumer M., Maca Th., Gschwandtner ME, Minar E.
OUTCOME OF CONSERVATIVE MEDICAL TREATMENT OF PATIENTS WITH INFRARENAL ABDOMINAL
AORTIC ANEURYSMS.Wien Klin Wochenschr 2002,Nov.;114(21-22):898-903. 0.57
Funovics MA, Lackner B, Cejna M, Peloschek P, Sailer J, Philipp MO, Maca T, Ahmadi A, Minar E
and Lammer J.PREDICTORS OF LONG-TERM RESULTS AFTER TREATMENT OF ILIAC ARTERY
OBLITERATION BY TRANSLUMINAL ANGIOPLASTY.Cardiovasc Intervent Radiol
2002 Sep-Oct;25(5):397-402. 0.91
Mlekusch W., Schillinger M., Sabeti S., Maca Th., Ahmadi R., Minar E.
CLINICAL OUTCOME AND PROGNOSTIC FACTORS FOR ISCHEMIC ULCERS TREATED WITH
PTA IN LOWER LIMBS. Eur J Vasc Endovasc Ther 2002 Aug;24(2):176-81. 1.56
A. Rezaie-Majd, T. Maca, R. Bucek, P. Valent, M.R. Müller, P. Husslein, A. Kashanipour, E. Minar and
M. Baghstanian. SIMVASTATIN REDUCES EXPRESSION OF CYTOKINES INTERLEUKIN-6,
INTERLEUKIN-8 AND MONOCYTE CHEMOATTRACTANT PROTEIN-1 IN CIRCULATING MONOCYTES
FROM HYPERCHOLESTEROLEMIC PATIENTS.Arterioscl Thromb Vasc Biol 2002 Jul;22(7):1194-9. 5.11
Ahmadi R, Schillinger M, Maca T, Minar E.
FEMOROPOPLITEAL ARTERIES: IMMEDIATE AND LONG-TERM RESULTS WITH A DACRON-COVERED
STENT-GRAFT.Radiology. 2002 May; 223(2):345-50. 4.13
Ahmadi R, Willfort A, Lang W, Schillinger M, Alt E, Gschwandtner ME, Haumer M, Maca T, Ehringer H,
Minar E. CAROTID ARTERY STENTING: EFFECT OF LEARNING CURVE AND INTERMEDIATE-TERM
MORPHOLOGICAL OUTCOME.J Endovasc Ther. 2001 Dec; 8(6):539-46. 4.33
Ahmadi R, Willfort A, Lang W, Schillinger M, Alt E, Gschwandtner ME, Haumer M, Maca T, Ehringer H,
Minar E. CAROTID ARTERY STENTING: EFFECT OF LEARNING CURVE AND INTERMEDIATE-TERM
MORPHOLOGICAL OUTCOME.J Endovasc Ther. 2001 Dec; 8(6):539-46. 4.33
Ziegler S, Schillinger M, Maca TH, Minar E.
POST-THROMBOTIC SYNDROME AFTER PRIMARY EVENT OF DEEP VENOUS THROMBOSIS 10 TO 20
YEARS AGO.Thromb Res. 2001 Jan 15; 101(2): 23-33. 1.32
Bucek RA, Schnurer G, Ahmadi A, Maca TH, Meissl G, Minar E.
A SEVERE CASE OF VASCULAR THORACIC OUTLET SYNDROME.
Wien Klin Wochenschr. 2000 Nov 24; 112(22): 973-7. 0.57
Bucek RA, Maca T, Ahmadi R, Minar E.
TEMPORARY VENA CAVA FILTERS DO NOT ALWAYS PROTECT FROM FATAL PULMONARY EMBOLISM.
Vasa. 2000 Nov; 29(4): 292-4. 0.82
Bucek RA, Maca T, Ahmadi R, Minar E.
TEMPORARY VENA CAVA FILTERS DO NOT ALWAYS PROTECT FROM FATAL PULMONARY EMBOLISM.
Vasa. 2000 Nov; 29(4): 292-4. 0.82
Pokrajac B, Potter R, Maca T, Fellner C, Mittlbock M, Ahmadi R, Seitz W, Minar E.
INTRAARTERIAL (192)IR HIGH-DOSE-RATE BRACHYTHERAPY FOR PROPHYLAXIS OF RESTENOSIS
AFTER FEMOROPOPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY: THE PROSPECTIVE
RANDOMIZED VIENNA-2-TRIAL RADIOTHERAPY PARAMETERS AND RISK FACTORS ANALYSIS.
Int J Radiat Oncol Biol Phys. 2000 Nov 1;48(4): 923-31. 3.05
A. Stümpflen, A. Ahmadi, M. Atteneder, M. Gschwandtner, S. Hofmann, T. Maca, G. Schnürer,
E. Minar.EFFECTS ON TRANSVENOUS REGIONAL GUANETHIDINE BLOCK IN THE TREATMENT OF
CRITICAL FINGER ISCHEMIA.Angiology - Journal of Vascular Diseases 2000 Feb;51(2): 115-22.
0.62
B. Stoiser, T. Maca, F. Thalhammer, U. Hollenstein, I. El-Menyawi, M. Burgmann.
SERUM NITRATE CONCENTRATIONS IN PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE
DISEASE.VASA 1999; 28: 181-184 0.82
M.E. Gschwandtner, E. Minar, A. Ahmadi, M. Haumer, M. Hülsmann, T. Maca, G. Schnürer, A.
Willfort, P. Polterauer,G. Meissl, H. Ehringer.IMPACT OF DIFFERENT THERAPEUTIC ALTERNATIVES
IN TREATMENT OF SEVERE LIMB ISCHEMIA: EXPERIENCES ON 190 CONSECUTIVE PATIENTS AT A
DEPARTMENT OF MEDICAL ANGIOLOGY.VASA 1999; 28: 271-278. 0.82
E. Minar, B. Pokrajac, R. Ahmadi, Th. Maca, H. Ehringer.BRACHYTHERAPY FOR PROPHYLAXIS OF
RESTENOSIS AFTER LONG-SEGMENT FEMOROPOPLITEAL ANGIOPLASTY: PILOT STUDY.Radiology
1998; 208: 173-179 4.13
Heinz Burgmann, Apostolos Georgopoulos, Wolfgang Graninger, Renate Koppensteiner,
Thomas Maca,Erich Minar,Barbara Schneider, Andreas Stümpflen, Herbert Ehringer.TISSUE
CONCENTRATION OF ANTIBIOTICS NEAR ISCHEMIC ULCERS IS MUCH HIGHER USING
TRANSVENOUS APPLICATION IN BIER'S ARTERIAL ARREST: COMPARISON WITH INTRAVENOUS
AND INTRAARTERIAL APPLICATION OF CLINDAMYCIN AND GENTAMICIN IN SYNOPSIS WITH THEIR
CORRESPONDING BLOOD CONCENTRATIONS.Lancet 1996; 348: 781-783. 15.94
H.Burgmann, U.Hollenstein, T.Maca, K.Zedwitz-Liebenstein, F.Thalhammer, R.Koppensteiner,
H.Ehringer,W.Graninger. INCREASED SERUM LAMININ AND ANGIOGENIN CONCENTRATIONS IN
PATIENTS WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE.J Clin Pathol 1996; 49: 1-3. 1.422
R.Katzenschlager, A.Ahmadi, E.Minar, R.Koppensteiner, Th.Maca, K.Pikesch, A.Stümpflen,
A.Ugurluoglu, H.Ehringer.FEMOROPOPLITEAL ARTERY: INITIAL AND 6-MONTH RESULTS OF COLOR-
DUPLEX US-GUIDED PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY.
Radiology 1996; 199: 331-334. 4.13
M.E.Gschwandtner, R.Koppensteiner, Th.Maca, E.Minar, B.Schneider, G.Schnürer and Ehringer.
SPONTANEOUS LASER DOPPLER FLUX DISTRIBUTION IN ISCHEMIC ULCERS AND THE EFFECTOF PROSTANOIDS: A CROSSOVER STUDY COMPARING THE ACUTE ACTION OF PROSTAGLANDIN E1 AND ILOPROST VS. SALINE.Microvascular Research 1996; 51: 29-38. 1.775
E.Minar, A.Ahmadi, R.Koppensteiner, Th.Maca, A.Stümpflen, A.Ugurluoglu, H.Ehringer.COMPARISON
BETWEEN HIGH-DOSE AND LOW-DOSE ASPIRIN ON RESTENOSIS AFTER
FEMOROPOPLITEAL PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY.
Circulation 1995; 91: 2167-2173. 10.89
R.Katzenschlager, A.Ugurluoglu, A.Ahmadi, M.Hülsmann, R.Koppensteiner, E.Larch, Th.Maca,
E.Minar,A.Stümpflen,H.Ehringer.INCIDENCE OF PSEUDOANEURYSM AFTER DIAGNOSTIC AND
THERAPEUTIC ANGIOGRAPHY.Radiology 1995; 195: 463-466. 4.13
M.Raderer, Th.Maca, M.Hejna, G.Weinländer, J.Kastner, G.Kornek, Th.Tetzner, W.Scheithauer.
TOXICITY PROFILE OF THE NOVEL CHEMOSENSITIZER DEXVERAPAMIL.
Onkologie 1995; 18: 462-467. 0.380
P.Fasching, K.Derfler, Th.Maca, S.Kurzemann, K.Howorka, B.Schneider, M.Zirm, W.Waldhäusl.
FEASIBILITY AND EFFICACY OF INTENSIVE INSULIN THERAPY IN TYPE I DIABETES MELLITUS
IN PRIMARY CARE.Diabetic Medicine 1994; 11: 836-842. 2.73
 
BUCHBEITRAG
Diabetes in der Praxis; W.Waldhäusl, F.A.Gries (Hrsg.), Springer-Verlag 1993. Kapitel: Arterielle
Verschlußkrankheit bei Diabetes Mellitus; H. Ehringer, R. Koppensteiner,
T. Maca. S.370-393.
K.Derfler, M.M.Hirschl, P.Fasching, Th.Maca, G.Heinz, W.Waldhäusl.PROGNOSE VON TYPI-/
TYPII-DIABETIKERN MIT TERMINALER NIERENINSUFFIZIENZ
BZW. UNTER NIERENERSATZTHERAPIE.Diabetes und Stoffwechsel 1992; 1: 212-217.

 

  Copyright © 2008 Prim. Dr. Thomas MACA. Alle Rechte vorbehalten.